Description
Chemical name:(Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
Formula: C26H29NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
TAMOXIFEN 20mg – PARA PHARMA
Tamoxifen 20 is a medication that is commonly used in the treatment of breast cancer in women. Its active substance is Tamoxifen Citrate, which belongs to the class of Selective Estrogen Receptor Modulators (SERMs).
One of the key characteristics of Tamoxifen 20 is its long active half-life, which is typically between 5-7 days. It works by inhibiting the growth of breast cancer cells that are stimulated by estrogen. Tamoxifen is also an estrogen antagonist, which means that it blocks the effects of estrogen on the breast tissue, reducing the risk of cancer recurrence.
Tamoxifen 20 is available in the form of 50 pills (tablets) of 20mg each. The usual dosage for Tamoxifen 20 is between 10-30mg per day, depending on the patient’s condition and the severity of their breast cancer.
One of the benefits of using Tamoxifen 20 is that it does not usually cause acne, water retention, HBR (hair loss), hepatotoxicity or aromatization. However, some patients may experience side effects such as hot flashes, nausea, and fatigue when taking Tamoxifen.
The manufacturer of Tamoxifen 20 is Para Pharma, a leading pharmaceutical company that specializes in the development and manufacturing of a variety of high-quality medications.
In conclusion, Tamoxifen 20 is a safe and effective medication that is used in the treatment of breast cancer in women. It is characterized by its long active half-life, its classification as a SERM, and its ability to reduce the risk of cancer recurrence in patients. Despite the possibility of side effects, Tamoxifen 20 remains an effective medication for breast cancer treatment.
Reviews
There are no reviews yet.